News

AVEO Pharma claims that Tivozanib, an investigational new drug, is a highly potent and selective inhibitor of VEGF receptors 1, 2 and 3, exhibiting picomolar inhibitory activity against

In the Phase I trial, ReNeuron’s ReN001stem cell therapy is being administered to stroke patients who have been left disabled by an ischaemic stroke. The PISCES study (Pilot

VR040 is Vectura’s proprietary formulation of apomorphine, delivered to the bloodstream by inhalation through the lungs using the company’s proprietary dry powder inhalation (DPI) technology. The results of

Biostar Pharma has posted a net income of $3.43m for the third quarter 2010, or $0.13 per diluted share, compared to net income of $3.13m, or $0.13 per

The company said that the purpose of the Innovation Credit is to reduce the financial risk for entrepreneurs and, as such, repayment of the credit, contributing 35% of

Elder Pharma has posted a net profit of INR135.38m for the second quarter 2010, compared to net profit of INR84.91m for the comparable period in 2009. For the

Apricus Bio said that Vitaros incorporates alprostadil, a well-recognised vasodilator that is currently marketed as an injectable product or an intra-urethral insert product for patients with erectile dysfunction.

Orazol is a tablet formulation of zoledronic acid, made possible by Merrion’s proprietary Gipet technology, for which there are issued US Orazol patents to 2027. Merrion said that

Lpath said that the first patent (US 7,829,674) contains claims covering the composition of matter for its anti-Sphingosine-1-Phosphate (S1P) antibody, sonepcizumab, the active component in Lpath’s two lead